Evaluation and Treatment for Older Men with Elevated PSA

摘要: The management of elderly men presenting with asymptomatic, elevated PSA levels requires careful consideration the risks and benefits biopsy, cancer detection, subsequent treatment. In over age 75 years, levels, prevalence prostate is high, but benefit treatment not clear. risk mortality declines as competing grow. As such, patient health longevity mainstay decision-making in this clinical scenario. If healthy, further evaluation MRI, predictive nomograms, and/or selective biomarkers may allow selection at greatest harboring cancers which potentially affect natural longevity. manner, all 76 modestly will require those few who remain might still from early detection.